|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 164.2 USD | +1.05% |
|
-2.83% | +5.99% |
| Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
| Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
On May 11, 2022, AbbVie Inc announced that at its annual general meeting of shareholders held on May 6, 2022, a shareholder proposal relating to adopt a policy to require an independent chair, was not approved.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.99% | 291B | |
| +28.79% | 676B | |
| +25.25% | 554B | |
| -7.64% | 349B | |
| +15.00% | 318B | |
| +3.40% | 210B | |
| -0.33% | 204B | |
| -9.73% | 194B | |
| -11.71% | 144B | |
| -8.32% | 142B |
ABBVIE INC. 
